GLP-1 Receptor Agonists and Uses Thereof
US-2025340544-A1 · Nov 6, 2025 · US
This page is not indexed by search engines while we improve data quality.
Limberakis Chris patents
Limberakis Chris is listed as an inventor on 31 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Limberakis Chris |
| Total patents | 31 |
| First publication | May 17, 2016 |
| Latest publication | Nov 6, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
GLP-1 Receptor Agonists and Uses Thereof
US-2025270196-A1 · Aug 28, 2025 · US
Glp-1 receptor agonists and uses thereof
US-2025257052-A1 · Aug 14, 2025 · US
GLP-1 receptor agonists and uses thereof
US-12378230-B2 · Aug 5, 2025 · US
GLP-1 receptor agonists and uses thereof
US-12331041-B2 · Jun 17, 2025 · US
GLP-1 receptor agonists and uses thereof
US-12319669-B2 · Jun 3, 2025 · US
GLP-1 Receptor Agonists and Uses Thereof
US-2024132483-A1 · Apr 25, 2024 · US
GLP-1 Receptor Agonists and Uses Thereof
US-2024059679-A1 · Feb 22, 2024 · US
Glp-1 receptor agonists and uses thereof
US-2024034725-A1 · Feb 1, 2024 · US
GLP-1 receptor agonists and uses thereof
US-11858916-B2 · Jan 2, 2024 · US
Recent patents
Latest publications not already listed above.
GLP-1 receptor agonists and uses thereof
US-11802121-B2 · Oct 31, 2023 · US
Glp-1 receptor agonists and uses thereof
US-2023124938-A1 · Apr 20, 2023 · US
Solid Forms of 2-((4-((S)-2-(5-Chloropyridin-2-yl)-2-methylbenzo[d][1,3]dioxol-4-yl)piperidin-1-yl)methyl)-1-(((S)-oxetan-2-yl)methyl)-1H-benzo[d]imidazole-6-carboxylic acid, 1,3-Dihydroxy-2-(hydroxymethyl)propan-2-amine Salt
US-2023045419-A1 · Feb 9, 2023 · US
Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and related diseases
US-2022387402-A1 · Dec 8, 2022 · US
GLP-1 receptor agonists and uses thereof
US-11512070-B2 · Nov 29, 2022 · US
GLP-1 Receptor Agonists and Uses Thereof
US-2021332034-A1 · Oct 28, 2021 · US
GLP-1 Receptor Agonists and Uses Thereof
US-2021163455-A1 · Jun 3, 2021 · US
GLP-1 receptor agonists and uses thereof
US-10934279-B2 · Mar 2, 2021 · US
Glp-1 receptor agonists and uses thereof
US-2021047298-A1 · Feb 18, 2021 · US
GLP-1 receptor agonists and uses thereof
US-10851081-B2 · Dec 1, 2020 · US
Glp-1 receptor agonists and uses thereof
US-2020255406-A1 · Aug 13, 2020 · US
GLP-1 receptor agonists and uses thereof
US-10683281-B2 · Jun 16, 2020 · US
GLP-1 receptor agonists and uses thereof
US-10676465-B2 · Jun 9, 2020 · US
GLP-1 receptor agonists and uses thereof
US-10669259-B2 · Jun 2, 2020 · US
GLP-1 Receptor Agonists and Uses Thereof
US-2019382387-A1 · Dec 19, 2019 · US
GLP-1 Receptor Agonists and Uses Thereof
US-2019382388-A1 · Dec 19, 2019 · US
GLP-1 Receptor Agonists and Uses Thereof
US-2019382384-A1 · Dec 19, 2019 · US
GLP-1 Receptor Agonists and Uses Thereof
US-2019119255-A1 · Apr 25, 2019 · US
GLP-1 receptor agonists and uses thereof
US-10208019-B2 · Feb 19, 2019 · US
GLP-1 Agonists and Uses Thereof
US-2018170908-A1 · Jun 21, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Pfizer | 31 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P3/04 | 30 |
| C07D471/04 | 29 |
| C07D405/14 | 29 |
| A61P3/00 | 29 |
| A61P3/10 | 29 |